Journals / Turkish Journal of Hematology / 2019 / Cilt: 36 - Sayı: 1

Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives

Pages
53–54
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

SRIWIJITALAI, W., WIWANITKIT, V. (2019). Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives. Turkish Journal of Hematology, Cilt: 36 - Sayı: 1, 53–54. https://ajindex.com/articles/412381

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Eren R, Suyanı E. Early direct antiglobulin test negativity after bendamustine and rituximab treatment in chronic lymphocytic leukemia: two cases. Turk J Hematol 2018;35:312-313
  2. Hubinont PO. The prozone phenomenon in haemagglutination reactions; with special reference to the quantitative antiglobulin test. Br Med J 1951;2:708-711
  3. Salama A, Mueller-Eckhardt C. Elimination of the prozone effect in the antiglobulin reaction by a simple modification. Vox Sang 1982;42:157- 159
  4. Ceppellini R. Causes of error in interpretation of direct Coombs’ test; false negative reaction due to prozone and false positive reaction due to cold autoantibodies. Sangue 1951;24:158-159.